QA: Axsome Therapeutics Inc. in us_pharma/2019

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001579428_2020_Axsome_Therapeutics_Inc.pdf

Logs

warning Missing logo subcommand.report {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001579428')"}

Graph

Absolute values for 0001579428, Axsome Therapeutics Inc.

  xvar xval
0 AssetsCurrent 220,379,262
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 30,623
3 remainder_Assets 139,875
4 LiabilitiesCurrent 24,494,745
5 LiabilitiesNoncurrent 17,332,626
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 13,598,030
9 ResearchAndDevelopmentExpense 53,647,067
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome -1,100,089
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 220,549,760
1 Liabilities 41,827,371
2 Expenses 67,245,097
3 Revenues 0
4 StockholdersEquity 178,722,389
5 NetIncome -68,345,186
6 ComprehensiveNetIncome -68,345,186
7 BaseVar 165,361,158
8 EconomicCapitalRatio 1.82

Edgar->Model Mapping

Feature Distribution

Change over Time